Best Practice No 172: pituitary gland pathology
- PMID:12890801
- PMCID: PMC1770019
- DOI: 10.1136/jcp.56.8.561
Best Practice No 172: pituitary gland pathology
Abstract
This article reviews published evidence on the diagnosis and classification of pituitary gland tumours and the relevance of histological and genetic features to prognosis. Much of the literature is devoted to the histological, ultrastructural, and immunocytochemical classification of pituitary adenomas (extensively supported by multicentre studies), with little consensus on the identification of prognostic features in adenomas, particularly in relation to invasion. There is a lack of correspondence between clinical and pathological criteria to identify and classify invasion, and a need to reassess the nomenclature and diagnostic criteria for invasive adenomas and carcinomas. Recent cytogenetic, genetic, and molecular biological studies have identified no consistent abnormalities in relation to pituitary tumour progression, although many genes are likely to be involved. In light of these uncertainties, an approach to the diagnosis and classification of pituitary adenomas is suggested, based on robust criteria from earlier studies and incorporating provisional data that require reassessment in large prospective studies with an adequate clinicopathological database.
Figures

Similar articles
- My approach to pathology of the pituitary gland.Al-Brahim NY, Asa SL.Al-Brahim NY, et al.J Clin Pathol. 2006 Dec;59(12):1245-53. doi: 10.1136/jcp.2005.031187.J Clin Pathol. 2006.PMID:17142570Free PMC article.Review.
- MicroRNAs and Target Genes in Pituitary Adenomas.Feng Y, Mao ZG, Wang X, Du Q, Jian M, Zhu D, Xiao Z, Wang HJ, Zhu YH.Feng Y, et al.Horm Metab Res. 2018 Mar;50(3):179-192. doi: 10.1055/s-0043-123763. Epub 2018 Jan 19.Horm Metab Res. 2018.PMID:29351706Review.
- Computational analysis identifies invasion-associated genes in pituitary adenomas.Cao C, Wang W, Ma C, Jiang P.Cao C, et al.Mol Med Rep. 2015 Aug;12(2):1977-82. doi: 10.3892/mmr.2015.3564. Epub 2015 Mar 27.Mol Med Rep. 2015.PMID:25824863
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G; members of HYPOPRONOS; Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A.Trouillas J, et al.Acta Neuropathol. 2013 Jul;126(1):123-35. doi: 10.1007/s00401-013-1084-y. Epub 2013 Feb 12.Acta Neuropathol. 2013.PMID:23400299
- Proliferation parameters for pituitary adenomas.Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F, Thierauf P.Buchfelder M, et al.Acta Neurochir Suppl. 1996;65:18-21. doi: 10.1007/978-3-7091-9450-8_7.Acta Neurochir Suppl. 1996.PMID:8738487Review.
Cited by
- Apparent diffusion coefficient and pituitary macroadenomas: pre-operative assessment of tumor atypia.Tamrazi B, Pekmezci M, Aboian M, Tihan T, Glastonbury CM.Tamrazi B, et al.Pituitary. 2017 Apr;20(2):195-200. doi: 10.1007/s11102-016-0759-5.Pituitary. 2017.PMID:27734275
- Segmented retinal analysis in pituitary adenoma with chiasmal compression: A prospective comparative study.Agarwal R, Jain VK, Singh S, Charlotte A, Kanaujia V, Mishra P, Sharma K.Agarwal R, et al.Indian J Ophthalmol. 2021 Sep;69(9):2378-2384. doi: 10.4103/ijo.IJO_2086_20.Indian J Ophthalmol. 2021.PMID:34427226Free PMC article.
- Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells.del Pliego MG, Aguirre-Benítez E, Paisano-Cerón K, Valdovinos-Ramírez I, Rangel-Morales C, Rodríguez-Mata V, Solano-Agama C, Martín-Tapia D, de la Vega MT, Saldoval-Balanzario M, Camacho J, Mendoza-Garrido ME.del Pliego MG, et al.Int J Clin Exp Pathol. 2013;6(3):458-68. Epub 2013 Feb 15.Int J Clin Exp Pathol. 2013.PMID:23413122Free PMC article.
- Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes.Zhang J, Gao H, Zhang Y.Zhang J, et al.Oncol Lett. 2017 Jun;13(6):4533-4539. doi: 10.3892/ol.2017.5997. Epub 2017 Apr 5.Oncol Lett. 2017.PMID:28599454Free PMC article.
- Visual Outcomes after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas: Our Institutional Experience.van Essen MJ, Muskens IS, Lamba N, Belunek SFJ, van der Boog ATJ, Amelink GJ, Gosselaar PH, van Doormaal TPC, Stades AME, Verhoeff JJC, van Genderen MM, Eenhorst CAE, Broekman MLD.van Essen MJ, et al.J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e79-e87. doi: 10.1055/s-0039-3402020. Epub 2020 Feb 3.J Neurol Surg B Skull Base. 2021.PMID:34306920Free PMC article.
References
- Asa SL. Tumors of the pituitary gland. Atlas of tumor pathology. 3rd series, Fascicle 22. Washington: Armed Forces Institute of Pathology, 1998.
- Kaye AH, Laws ER, eds. Brain tumors. An encyclopedic approach. Edinburgh: Churchill Livingstone, 1995.
- Thapar K, Kovacs K. Neoplasms of the sellar region. In: Bigner DD, McLendon R, Bruner J, eds. Russell and Rubinstein’s pathology of tumors of the nervous system, 6th ed. London: Arnold, 1998.
- Horvath E, Scheithauer BW, Kovacs K, et al. Hypothalamus and pituitary. In Graham DI, Lantos PL, eds. Greenfield’s neuropathology, 7th ed. London: Arnold, 2002.
- Ironside JW, Moss TH, Louis DN, et al. Diagnostic pathology of nervous system tumours. Edinburgh: Churchill Livingstone, 2002.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical